You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

human cytomegalovirus

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cytomegalovirus Infections Trial in Manchester (SPYVAC01)

Not yet recruiting
  • Cytomegalovirus Infections
  • SPYVAC01
  • Manchester, United Kingdom
    Medicines Evaluation Unit
Nov 20, 2023

Cytomegalovirus Infections Trial in Fukuoka (V160, Placebo)

Completed
Has Results
  • Cytomegalovirus Infections
  • V160
  • Placebo
  • Fukuoka, Japan
    Souseikai PS Clinic ( Site 0001)
Nov 19, 2021

Maternal Cytomegalovirus Infections, Cytomegalovirus Congenital Trial in Birmingham (CMV Risk-Reduction Intervention, Stress

Recruiting
  • Maternal Cytomegalovirus Infections
  • Cytomegalovirus Congenital
  • CMV Risk-Reduction Intervention
  • Stress Reduction Messaging
  • Birmingham, Alabama
    University of Alabama at Birmingham
Dec 13, 2022

Cytomegalovirus Infections Trial (V160 Low Dose IM, V160 Medium Dose IM, V160 High Dose IM)

Completed
Has Results
  • Cytomegalovirus Infections
  • V160 Low Dose IM
  • +8 more
  • (no location specified)
Sep 30, 2021

Lung Transplant, CMV Trial in Pittsburgh (Letermovir, Valganciclovir)

Recruiting
  • Lung Transplant
  • CMV
  • Pittsburgh, Pennsylvania
  • +1 more
May 16, 2022

Glioblastoma Trial in Durham (Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF, Temozolomide, Tetanus-Diphtheria

Suspended
  • Glioblastoma
  • Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF
  • +4 more
  • Durham, North Carolina
    Duke University Medical Center
Aug 16, 2022

Cytomegalovirus Infections, Influenza Trial in Stanford (Fluzone® 2012-2013 Formula NDC No 498281-012-50)

Completed
Has Results
  • Cytomegalovirus Infections
  • Influenza
  • Fluzone® 2012-2013 Formula NDC No 498281-012-50
  • Stanford, California
    Stanford University School of Medicine
Sep 21, 2021

HIV, Cytomegalovirus, CMV Trial in United States (Letermovir 240 MG Oral Tablet, Letermovir 480 MG Oral Tablet, Combination ART)

Recruiting
  • HIV Infections
  • +2 more
  • Letermovir 240 MG Oral Tablet
  • +2 more
  • Birmingham, Alabama
  • +18 more
Jun 20, 2022

Cytomegalovirus Infections Trial in United States (Pentamer (low)/gB(low)/Adjuvant vaccine, Pentamer (med)/gB(low)/Adjuvant

Recruiting
  • Cytomegalovirus Infections
  • Pentamer (low)/gB(low)/Adjuvant vaccine
  • +4 more
  • Long Beach, California
  • +14 more
Jul 15, 2022

Cytomegalovirus Infections, HIV, Vaccine Trial in United States (CMV-MVA Triplex, Placebo)

Recruiting
  • Cytomegalovirus Infections
  • +2 more
  • CMV-MVA Triplex
  • Placebo
  • Birmingham, Alabama
  • +11 more
Jun 20, 2022

Congenital Cytomegalovirus Infection, Maternal Cytomegalovirus Infection Trial in United States (CMV hyperimmune globulin,

Completed
  • Congenital Cytomegalovirus Infection
  • Maternal Cytomegalovirus Infection
  • CMV hyperimmune globulin
  • Placebo
  • Birmingham, Alabama
  • +15 more
Sep 21, 2021

Cytomegalovirus Retinitis, HIV Trial in United States (Sevirumab, Foscarnet sodium, Ganciclovir)

Completed
  • Cytomegalovirus Retinitis
  • HIV Infections
  • Birmingham, Alabama
  • +19 more
Oct 28, 2021

Glioblastoma, Astrocytoma, Grade IV, Giant Cell Glioblastoma Trial in Durham (Unpulsed DCs, Td, Human CMV pp65-LAMP mRNA-pulsed

Completed
Has Results
  • Glioblastoma
  • +3 more
  • Unpulsed DCs
  • +6 more
  • Durham, North Carolina
    Duke University Medical Center
Jan 3, 2022

SARS-CoV-2, Seasonal Influenza, Respiratory Syncytial Virus Trial in United States (mRNA-1273, mRNA-1010, mRNA-1345)

Recruiting
  • SARS-CoV-2
  • +3 more
  • mRNA-1273
  • +4 more
  • Hollywood, Florida
  • +7 more
May 25, 2022

Cytomegalovirus Infections Trial in Vancouver, Halifax, Pierrefonds (VBI-1501A 0.5 µg, VBI-1501A 1.0 µg, VBI-1501A 2.0 µg)

Completed
Has Results
  • Cytomegalovirus Infections
  • VBI-1501A 0.5 μg
  • +4 more
  • Vancouver, British Columbia, Canada
  • +2 more
Apr 16, 2020

HIV-infection/Aids, Human Herpesvirus 4 Infections, Cytomegalovirus Infections Trial (NRTIs, Darunavir, Ritonavir)

Withdrawn
  • HIV-infection/Aids
  • +4 more
  • (no location specified)
Nov 8, 2020

Adenovirus Infection, BK Virus Infection, Cytomegalovirus Infections Trial in Worldwide (Posoleucel (ALVR105), Placebo)

Recruiting
  • Adenovirus Infection
  • +5 more
  • Posoleucel (ALVR105)
  • Placebo
  • Birmingham, Alabama
  • +60 more
Mar 30, 2022

Cytomegalovirus Infections, HIV Trial in Puerto Rico, United States (Valganciclovir)

Completed
  • Cytomegalovirus Infections
  • HIV Infections
  • Birmingham, Alabama
  • +56 more
Oct 28, 2021

Glioblastoma Trial (PEP-CMV vaccine)

Not yet recruiting
  • Glioblastoma
  • PEP-CMV vaccine
  • (no location specified)
Nov 9, 2023

CMV Disease Trial in Worldwide (Letermovir, Valganciclovir, Acyclovir (ACV))

Completed
  • CMV Disease
  • Birmingham, Alabama
  • +93 more
Apr 8, 2022

HCMV Trial in Worldwide (CSJ148, Placebo)

Completed
Has Results
  • HCMV
  • CSJ148
  • Placebo
  • San Francisco, California
  • +16 more
Dec 9, 2020

Cytomegalovirus Infection Trial in Boston (mRNA-1647, Placebo)

Not yet recruiting
  • Cytomegalovirus Infection
  • mRNA-1647
  • Placebo
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 4, 2023

Biomarkers of Cytomegalovirus Fetal Infection and Disease

Recruiting
  • Cytomegalovirus Congenital
  • Bio-specimen collected
  • Paris, France
    Hôpital Necker Enfants-Malades
Nov 4, 2022

Congenital Cytomegalovirus Infection Trial (Letermovir)

Not yet recruiting
  • Congenital Cytomegalovirus Infection
  • (no location specified)
Nov 1, 2023

Cytomegalovirus Infection Trial in United States (mRNA-1647, Placebo)

Not yet recruiting
  • Cytomegalovirus Infection
  • mRNA-1647
  • Placebo
  • Birmingham, Alabama
  • +25 more
Nov 10, 2023